Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novartis psoriasis drug approval could upend market
Novartis psoriasis drug approval could upend market
Novartis psoriasis drug approval could upend market
Submitted by
admin
on January 22, 2015 - 9:55am
Source:
Medical Marketing and Media
News Tags:
Novartis
psoriasis
Cosentyx
Amgen
Stelara
Enbrel
Headline:
Novartis psoriasis drug approval could upend market
Do Not Allow Advertisers to Use My Personal information
